Skip to main content

Cellular interaction and Toxicology with engineered Nanoparticles

Objective

The present proposal aims at the development of innovative multidisciplinary sets of tests and indicators for toxicological profiling of nanoparticles (NPs) as well as unravelling the correlation between the physicochemical characteristics of NPs and their toxic potential on various organs of the human body. For a comprehensive understanding of the complex data to be obtained on toxicology of NPs, based on in-vitro and ex-vivo studies, we will employ conventional toxicology combined with the methodologies of toxicogenomics, metabonomics, Knowledge Discovery from Data (KDD) and Data Mining (DM).

This research program is focused towards understanding the relation of size and surface chemistry on the deposition, uptake, translocation, and toxicity of a few s elected industrially important NPs as well as novel synthesized NPs, whose size and surface chemistry will be methodically modified. Since it was shown that the penetration of NPs into the human body proceeds principally through inhalation or orally, whereas penetration through healthy skin is restricted, we have chosen lung and intestine as the primary interacting tissues/organs with NPs, while liver, kidney and the immunological system have been selected to be the secondary major sites of interaction, following the penetration of NPs into the blood circulation.

The interaction of the NPs with these different target organs will be studied by making use of alternative methods to animal experimentation by employing in-vitro cell systems as well as ex-vivo studies based on precision-cut slices of lung, liver and kidney. The present proposal addresses the needs of the European society for assessing the risk of occupational and general population exposure to industrially manufactured NPs. It will generate new knowledge on potential health risk or the absence of it, providing objective arguments for recommendations and regulations.

Call for proposal

FP6-2004-NMP-TI-4
See other projects for this call

Funding Scheme

STREP - Specific Targeted Research Project

Coordinator

TEL AVIV UNIVERSITY
Address
Ramat Aviv
Tel Aviv
Israel

Participants (7)

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
France
Address
101 Rue De Tolbiac
Paris
COMMISSION OF THE EUROPEAN COMMUNITIES - DIRECTORATE GENERAL JOINT RESEARCH CENTRE
Belgium
Address
Rue De La Loi, 200
Brussels
BASF AKTIENGESELLSCHAFT
Germany
Address
Carl-bosch-strasse 38
Ludwigshafen
COLOROBBIA ITALIA SPA
Italy
Address
Via Pietramarina, 53
Sovigliana - Vinci
TP21 GMBH
Germany
Address
Tuerkenstrasse 4
Saarbruecken
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ
Germany
Address
Langenbeckstr.1
Mainz
WESTFÄLISCHE WILHELMS-UNIVERSITÄT, MÜNSTER
Germany
Address
Schlossplatz 2
Münster